TREACE MEDICAL CONCEPTS INC (TMCI) Stock Income Statement
NASDAQ:TMCI - Nasdaq - US89455T1097 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 209.36M | 187.12M | 141.80M | 94.40M | 57.40M | |||
| Cost Of Goods | 41.09M | 35.18M | 27.50M | 17.80M | 12.50M | |||
| Gross Profit | 168.26M | 151.94M | 114.30M | 76.60M | 44.90M | |||
| Operating Expenses | 223.95M | 203.37M | 149.20M | 93.10M | 44.00M | |||
| Research and Development | 20.59M | 15.44M | 13.60M | 10.20M | 5.80M | |||
| Selling, General, and Administrative Expenses | 203.36M | 187.93M | 135.60M | 82.90M | 38.20M | |||
| Operating Income | -55.69M | -51.43M | -34.80M | -16.50M | 900.00K | |||
| Interest Income/Expense | -379.00K | 1.56M | -3.20M | -4.00M | -4.50M | |||
| Other Income/Expense | 324.00K | 342.00K | N/A | N/A | N/A | |||
| Non Recurring Items | 0.00 | 0.00 | -4.80M | N/A | N/A | |||
| Income Before Taxes | -55.74M | -49.53M | -42.80M | -20.60M | -3.70M | |||
| Net Income | -55.74M | -49.53M | -42.80M | -20.70M | -4.30M | |||
| EBITDA | -47.27M | -46.08M | -32.67M | -15.81M | 2.11M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.90 | -0.81 | -0.77 | -0.43 | -0.09 | |||
| Non GAAP EPS | -0.85 | -0.81 | -0.77 | -0.41 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 80.37% | 81.20% | 80.61% | 81.14% | 78.22% | |||
| Profit Margin | -26.63% | -26.47% | -30.18% | -21.93% | -7.49% | |||
| Operating Profit Margin | -26.60% | -27.48% | -24.54% | -17.48% | 1.57% | |||
All data in USD